v3.26.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance at Mar. 31, 2024 $ 1 $ 278,899 $ (6,038) $ (211,119) $ 61,743
Balance (in Shares) at Mar. 31, 2024 9,399,404        
Net loss $ 0 0 0 (9,568) (9,568)
Stock-based compensation 0 730 0 0 730
Issuance of common stock upon cashless exercise of pre-funded warrants $ 0 0 0 0 0
Issuance of common stock upon cashless exercise of pre-funded warrants (in Shares) 740,457        
Issuance of common stock and warrants through private placement, net of offering costs $ 0 13,705 0 0 13,705
Issuance of common stock and warrants through private placement, net of offering costs (in Shares) 3,252,132        
Issuance of common stock upon exercise of common warrants $ 0 0 0 0 0
Issuance of common stock upon exercise of common warrants (in Shares) 326,113        
Balance at Mar. 31, 2025 $ 1 293,334 (6,038) (220,687) $ 66,610
Balance (in Shares) at Mar. 31, 2025 13,718,106       13,718,106
Net loss $ 0 0 0 (7,793) $ (7,793)
Stock-based compensation 0 798 0 0 798
Issuance of common stock upon exercise of pre-funded warrants $ 0 0 0 0 0
Issuance of common stock upon exercise of pre-funded warrants (in Shares) 960,456        
Issuance of common stock upon exercise of common warrants $ 0 4,281 0 0 4,281
Issuance of common stock upon exercise of common warrants (in Shares) 1,345,464        
Balance at Mar. 31, 2026 $ 1 $ 298,413 $ (6,038) $ (228,480) $ 63,896
Balance (in Shares) at Mar. 31, 2026 16,024,026       16,024,026